Global Medical REIT (NYSE:XRN) COO Buys $495,855.00 in Stock

Global Medical REIT Inc. (NYSE:XRN) COO Aaron Robert Roseth bought 13,500 shares of the stock in a transaction that occurred on Wednesday, August 12th. The shares were purchased at an average price of $36.73 per share, for a total transaction of $495,855.00. Following the purchase, the chief operating officer owned 13,500 shares in the company, valued at $495,855. This represents a ? increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Global Medical REIT Stock Performance

NYSE:XRN opened at $37.28 on Friday. The stock has a 50-day moving average price of $36.62 and a 200 day moving average price of $35.81. The stock has a market capitalization of $493.59 million, a P/E ratio of 10.02 and a beta of 1.09. Global Medical REIT Inc. has a 12-month low of $29.05 and a 12-month high of $39.93. The company has a current ratio of 0.59, a quick ratio of 0.68 and a debt-to-equity ratio of 1.37.

Global Medical REIT (NYSE:XRN) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $4.78 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $3.95. Global Medical REIT had a return on equity of 13.31% and a net margin of 36.82%.The company had revenue of $39.75 million for the quarter. Equities research analysts forecast that Global Medical REIT Inc. will post 2.89 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Citizens Jmp lifted their target price on Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a report on Tuesday, May 26th. Zacks Research raised Global Medical REIT to a “hold” rating in a report on Wednesday, July 22nd. Wall Street Zen lowered shares of Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Raymond James Financial began coverage on shares of Global Medical REIT in a research report on Wednesday, June 17th. They issued a “market perform” rating on the stock. Finally, Compass Point restated a “neutral” rating and issued a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Two analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $40.25.

Hedge Funds Weigh In On Global Medical REIT

Large investors have recently made changes to their positions in the company. AQR Capital Management LLC lifted its stake in Global Medical REIT by 9.5% in the first quarter. AQR Capital Management LLC now owns 58,538 shares of the company’s stock worth $512,000 after purchasing an additional 5,062 shares during the last quarter. Jones Financial Companies Lllp increased its stake in Global Medical REIT by 23,920.0% in the first quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company’s stock worth $210,000 after purchasing an additional 23,920 shares during the period. Goldman Sachs Group Inc. increased its stake in Global Medical REIT by 13.2% in the first quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company’s stock worth $3,400,000 after purchasing an additional 45,243 shares during the period. Strs Ohio bought a new stake in shares of Global Medical REIT during the first quarter worth $95,000. Finally, Envestnet Asset Management Inc. lifted its position in shares of Global Medical REIT by 39.5% during the second quarter. Envestnet Asset Management Inc. now owns 26,617 shares of the company’s stock worth $184,000 after purchasing an additional 7,536 shares during the last quarter. 57.52% of the stock is owned by hedge funds and other institutional investors.

Global Medical REIT News Roundup

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: CEO Mark Okey Decker, Jr. bought 8,000 shares at $35.88 and an additional 6,875 shares at $35.92, while COO Aaron Robert Roseth purchased 13,500 shares at $36.73. Director Charles Fitzgerald also acquired 14,000 shares at $35.78. The reported purchases represent more than $1.5 million of direct insider buying, a potentially bullish signal. Global Medical REIT CEO Purchases Shares
• Positive Sentiment: Global Medical REIT’s latest quarterly results significantly exceeded expectations: earnings per share were $4.78 versus the $0.83 consensus estimate, with revenue of $39.75 million. The company also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for investor interest.
• Neutral Sentiment: Analyst opinion remains mixed, with two Buy ratings, five Holds and one Sell. The average price target is $40.25, above the recent trading range, but Compass Point maintains a $38 target while Citizens JMP has a $42 target. The overall consensus rating is Hold.
• Neutral Sentiment: Institutional investors own approximately 57.52% of XRN. Recent filings show several funds increasing positions, although the disclosed transactions are not necessarily a near-term catalyst.
• Neutral Sentiment: Coverage also discusses Global Medical REIT’s rebranding and transition to Chiron Real Estate, which may create uncertainty about the company’s identity and strategic direction. Chiron Real Estate rebrand article
• Negative Sentiment: The REIT remains relatively leveraged, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68. High debt and limited liquidity could weigh on valuation if interest rates stay elevated or healthcare property conditions weaken.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.